ORG
Optimist Retirement Group Portfolio holdings
AUM
$209M
This Quarter Return
+1.21%
1 Year Return
+11.77%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$211M
AUM Growth
+$211M
(-4.6%)
Cap. Flow
-$9.26M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
57.13%
Holding
127
New
5
Increased
35
Reduced
65
Closed
8
Top Buys
Top Sells
| 1 |
Genuine Parts
GPC
|
$1.55M |
| 2 |
Pfizer
PFE
|
$1.23M |
| 3 |
BHP
BHP
|
$1.19M |
| 4 |
Diageo
DEO
|
$1.06M |
| 5 |
Organon & Co
OGN
|
$940K |
Sector Composition
| 1 | Industrials | 21.46% |
| 2 | Technology | 11.8% |
| 3 | Consumer Discretionary | 9.6% |
| 4 | Healthcare | 6.72% |
| 5 | Consumer Staples | 6.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
PACCAR
PCAR
$52.5B
| $38.9M | 18.38% |
373,501
-4,818
| -1% | -$501K |
|
2
SPDR Portfolio S&P 500 Growth ETF
SPYG
$40.4B
| $13.1M | 6.19% |
148,811
-2,303
| -2% | -$202K |
|
3
SPDR Portfolio S&P 500 Value ETF
SPYV
$28.1B
| $11.8M | 5.6% |
231,537
+7,040
| +3% | +$360K |
|
4
SPDR S&P 600 Small Cap Growth ETF
SLYG
$3.55B
| $11.7M | 5.56% |
130,041
+4,419
| +4% | +$399K |
|
5
SPDR S&P 600 Small Cap Value ETF
SLYV
$4.03B
| $11.7M | 5.54% |
134,278
+5,757
| +4% | +$502K |
|
6
Amazon
AMZN
$2.44T
| $10.5M | 4.98% |
47,990
| – | – |
|
7
Microsoft
MSFT
$3.77T
| $6.84M | 3.24% |
16,233
+14
| +0.1% | +$5.9K |
|
8
SPDR Portfolio Emerging Markets ETF
SPEM
$13.1B
| $5.99M | 2.83% |
155,987
+3,171
| +2% | +$122K |
|
9
SPDR Portfolio Developed World ex-US ETF
SPDW
$29.1B
| $5.87M | 2.78% |
171,940
+7,633
| +5% | +$261K |
|
10
Vanguard Small-Cap ETF
VB
$66.4B
| $4.3M | 2.04% |
17,911
+25
| +0.1% | +$6.01K |
|
11
Invesco QQQ Trust
QQQ
$364B
| $3.4M | 1.61% |
6,658
+2
| +0% | +$1.02K |
|
12
Broadcom
AVGO
$1.4T
| $3.38M | 1.6% |
14,574
-1,138
| -7% | -$264K |
|
13
Vanguard S&P 500 ETF
VOO
$726B
| $2.75M | 1.3% |
5,107
-42
| -0.8% | -$22.6K |
|
14
IBM
IBM
$227B
| $2.61M | 1.24% |
11,883
-242
| -2% | -$53.2K |
|
15
3M
MMM
$82.8B
| $2.47M | 1.17% |
19,103
-567
| -3% | -$73.2K |
|
16
Eli Lilly
LLY
$657B
| $2.46M | 1.16% |
3,182
+18
| +0.6% | +$13.9K |
|
17
Bristol-Myers Squibb
BMY
$96B
| $2.43M | 1.15% |
42,928
-708
| -2% | -$40K |
|
18
Gilead Sciences
GILD
$140B
| $2.41M | 1.14% |
26,081
-1,153
| -4% | -$107K |
|
19
Alliance Resource Partners
ARLP
$2.96B
| $2.38M | 1.12% |
90,404
-3,058
| -3% | -$80.4K |
|
20
AbbVie
ABBV
$372B
| $2.37M | 1.12% |
13,312
-250
| -2% | -$44.4K |
|
21
H&R Block
HRB
$6.74B
| $2.26M | 1.07% |
42,846
-236
| -0.5% | -$12.5K |
|
22
Kimberly-Clark
KMB
$42.8B
| $2.24M | 1.06% |
17,096
-582
| -3% | -$76.3K |
|
23
Verizon
VZ
$186B
| $2.22M | 1.05% |
55,550
-672
| -1% | -$26.9K |
|
24
Unilever
UL
$155B
| $2.19M | 1.04% |
38,644
-501
| -1% | -$28.4K |
|
25
British American Tobacco
BTI
$124B
| $2.18M | 1.03% |
59,904
-2,092
| -3% | -$76K |
|